- 26 Dec 2017, 13:29
#2473
Lots of new things happened in the pharmaceutical industry in 2017.
Top 10 Pharmaceutical Companies 2017
The global pharmaceutical market was estimated in USD 1.1 trillion in 2016. The global market is highly mature and consolidated. The top-10 pharmaceutical companies in this market had share of around 40% in 2016 and approximately 50% considering the top-15. A comparative analysis of the top-15 organizations was used to develop a ranking for these companies.
(Figures in Billion USD)
1. Pfizer – 52,824
2. Merck – 35,151
3. J & J – 33,464
4. Roche – 39,494
5. Sanofi – 35,850
6. Novartis – 32,562
7. Abbvie – 25,638
8. Astrazeneca – 23,002
9. Gilead – 29,953
10. Amgen – 22,991
World’s Most Admired Pharmaceutical Companies 2017
Reputation is extremely important for Pharmaceutical Companies. Like every year, Fortune collaborated with Korn Ferry Hay Group on the survey of corporate reputations. To determine the best-regarded companies in 51 industries, Korn Ferry Hay Group evaluated 680 companies in 28 countries. Executives, directors, and analysts have been asked to rate enterprises in their own industry. The list of Pharmaceutical Companies that made it to the top is here.
(Company and their scores)
1. J&J – 8.06
2. Roche – 7.33
3. Novartis – 7,33
4. Merck – 7.26
5. Amgen – 6.74
6. Pfizer – 6.63
7. Gilead sciences – 6.53
8. Abbvie – 6.48
9. Eli Lilly – 6.48
The Most Innovative Biotech Companies of 2017
Innovation is the key for the success of the Biotech industry. Hence, the innovation strategy of a biotech company must evolve constantly if it wants to remain competitive in the local and international market. Necessity is the mother of innovation, and so the successful biotech companies are always focused on their innovation initiatives in order to bring new products in the market for the benet of people. For this reason, the scientists and entrepreneurs working in this industry are imaginative, revolutionary, inventive, and ingenious, as well as industrious.
1. Medtronic – For simplifying diabetes management
2. Celmatix – For mining fertility data to assist conception
3. Johnson & Johnson – For incubating medical startups
4. 23Andme – for donating data in the name of research
5. Abbott – For making heart surgery safer with dissolvable stent
6. COLOR – For democratizing genetic testing
7. Patientslikeme – For united people with chronic diseases
8. Parker Institute For Cancer Immunotherapy – For collaborating on cancer cure
9. Braeburn Pharmaceuticals – For getting under opoid addict skin
10. Illumina – For taking cost of DNA sequencing to new lows
Top 10 Pharmaceutical Therapy Areas in 2017
Many new medications and treatments have emerged this year for improving the management and prognoses of patients suffering from serious diseases. Driven growing therapy areas such as oncology, anti-rheumatics, and anti-virals, the prescription drug sales are increasing significantly.
1. Oncology:
Sales (USD Billion): 93.7 Market Share: 11.7%
2. Anti-Rheumatics:
Sales (USD Billion): 53.3 Market Share: 6.6%
3. Antiviral:
Sales (USD Billion): 48.5 Market Share: 6%
4. Anti-Diabetics:
Sales (USD Billion): 43.6 Market Share: 5.4%
5. Bronchodilators:
Sales (USD Billion): 28.3 Market Share: 3.5%
6. Vaccines:
Sales (USD Billion): 27.5 Market Share: 3.4%
7. Anti-hypertensives:
Sales (USD Billion): 24.8 Market Share: 3.1%
8. Sensory organs:
Sales (USD Billion): 20.2 Market Share: 2.5%
9. Anti-Coagulants:
Sales (USD Billion): 14.1 Market Share: 1.8%
10. Immunosuppresants:
Sales (USD Billion): 11.6 Market Share: 1.4%
Top 10 Brands in the World 2017
The global prescription drug market is expected to grow by 6% from 2016 to 2022 to reach nearly USD 1.05 trillion by 2022. The top 20 drugs are manufactured by 14 companies and account for a total 10% of global prescription drug market in 2016. The total revenue generated by top 20 products was estimated to be USD 0.128 trillion. A large number of the drugs in the list are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV or HCV infections.
1. Humira – Adalimumab
2. Harvoni – Ledipasvir/sofosbuvir
3. Enbrel – Etanercept
4. Rituxan – Rituximab
5. Remicade – Infliximab
6. Revlimid – Lenalidomide
7. Avastin – Bevacizumab
8. Herceptin – Trastuzumab
9. Januvia – Sitagliptin
10. Lantus – Insulin Glargin
Reference: https://www.linkedin.com/pulse/pharma-2 ... ent-object
Top 10 Pharmaceutical Companies 2017
The global pharmaceutical market was estimated in USD 1.1 trillion in 2016. The global market is highly mature and consolidated. The top-10 pharmaceutical companies in this market had share of around 40% in 2016 and approximately 50% considering the top-15. A comparative analysis of the top-15 organizations was used to develop a ranking for these companies.
(Figures in Billion USD)
1. Pfizer – 52,824
2. Merck – 35,151
3. J & J – 33,464
4. Roche – 39,494
5. Sanofi – 35,850
6. Novartis – 32,562
7. Abbvie – 25,638
8. Astrazeneca – 23,002
9. Gilead – 29,953
10. Amgen – 22,991
World’s Most Admired Pharmaceutical Companies 2017
Reputation is extremely important for Pharmaceutical Companies. Like every year, Fortune collaborated with Korn Ferry Hay Group on the survey of corporate reputations. To determine the best-regarded companies in 51 industries, Korn Ferry Hay Group evaluated 680 companies in 28 countries. Executives, directors, and analysts have been asked to rate enterprises in their own industry. The list of Pharmaceutical Companies that made it to the top is here.
(Company and their scores)
1. J&J – 8.06
2. Roche – 7.33
3. Novartis – 7,33
4. Merck – 7.26
5. Amgen – 6.74
6. Pfizer – 6.63
7. Gilead sciences – 6.53
8. Abbvie – 6.48
9. Eli Lilly – 6.48
The Most Innovative Biotech Companies of 2017
Innovation is the key for the success of the Biotech industry. Hence, the innovation strategy of a biotech company must evolve constantly if it wants to remain competitive in the local and international market. Necessity is the mother of innovation, and so the successful biotech companies are always focused on their innovation initiatives in order to bring new products in the market for the benet of people. For this reason, the scientists and entrepreneurs working in this industry are imaginative, revolutionary, inventive, and ingenious, as well as industrious.
1. Medtronic – For simplifying diabetes management
2. Celmatix – For mining fertility data to assist conception
3. Johnson & Johnson – For incubating medical startups
4. 23Andme – for donating data in the name of research
5. Abbott – For making heart surgery safer with dissolvable stent
6. COLOR – For democratizing genetic testing
7. Patientslikeme – For united people with chronic diseases
8. Parker Institute For Cancer Immunotherapy – For collaborating on cancer cure
9. Braeburn Pharmaceuticals – For getting under opoid addict skin
10. Illumina – For taking cost of DNA sequencing to new lows
Top 10 Pharmaceutical Therapy Areas in 2017
Many new medications and treatments have emerged this year for improving the management and prognoses of patients suffering from serious diseases. Driven growing therapy areas such as oncology, anti-rheumatics, and anti-virals, the prescription drug sales are increasing significantly.
1. Oncology:
Sales (USD Billion): 93.7 Market Share: 11.7%
2. Anti-Rheumatics:
Sales (USD Billion): 53.3 Market Share: 6.6%
3. Antiviral:
Sales (USD Billion): 48.5 Market Share: 6%
4. Anti-Diabetics:
Sales (USD Billion): 43.6 Market Share: 5.4%
5. Bronchodilators:
Sales (USD Billion): 28.3 Market Share: 3.5%
6. Vaccines:
Sales (USD Billion): 27.5 Market Share: 3.4%
7. Anti-hypertensives:
Sales (USD Billion): 24.8 Market Share: 3.1%
8. Sensory organs:
Sales (USD Billion): 20.2 Market Share: 2.5%
9. Anti-Coagulants:
Sales (USD Billion): 14.1 Market Share: 1.8%
10. Immunosuppresants:
Sales (USD Billion): 11.6 Market Share: 1.4%
Top 10 Brands in the World 2017
The global prescription drug market is expected to grow by 6% from 2016 to 2022 to reach nearly USD 1.05 trillion by 2022. The top 20 drugs are manufactured by 14 companies and account for a total 10% of global prescription drug market in 2016. The total revenue generated by top 20 products was estimated to be USD 0.128 trillion. A large number of the drugs in the list are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV or HCV infections.
1. Humira – Adalimumab
2. Harvoni – Ledipasvir/sofosbuvir
3. Enbrel – Etanercept
4. Rituxan – Rituximab
5. Remicade – Infliximab
6. Revlimid – Lenalidomide
7. Avastin – Bevacizumab
8. Herceptin – Trastuzumab
9. Januvia – Sitagliptin
10. Lantus – Insulin Glargin
Reference: https://www.linkedin.com/pulse/pharma-2 ... ent-object